GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q1 2021 GlaxoSmithKline PLC Earnings Call Transcript

Apr 28, 2021 / 01:00PM GMT
Release Date Price: $38.76 (-0.08%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the analyst call on the GSK First Quarter 2021 Results. I will now hand you over to Iain Mackay, our CFO, who will introduce today's session.

Iain James Mackay
GlaxoSmithKline plc - CFO & Executive Director

Thank you. Good morning, good afternoon. Thank you for joining us for our first quarter 2021 results, which were issued earlier today. You should have received our press release and you can view the presentation on GSK's website. For those who are not able to view the webcast, slides that accompany today's call are located on the Investors section of the GSK website.

Before we begin, please refer to Slide 2 of our presentation for our cautionary statements. Speakers today are Emma Walmsley, Luke Miels, David Redfern, Brian McNamara and myself, Iain Mackay. Joining us for the Q&A portion of the call will be Dr. Hal Barron and Roger Connor. (Operator Instructions) Our presentation will last for approximately 30 minutes in order to maximize the opportunity for questions. And with that, I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot